The Harvard Corporation has accepted a recommendation not to dename the Arthur M. Sackler Museum and Building, the University announced today. The denaming request was originally submitted in October 2022 by a group of students who argued that Arthur Sackler’s association with, and indirect responsibility for, the opioid crisis warranted denaming. In 1952, Arthur Sackler cofounded, with his two brothers, the pharmaceutical company that would become Purdue Pharma. The report’s first argument was that Arthur Sackler played a role in developing the aggressive marketing practices that Purdue Pharma later used to advertise OxyContin. The committee emphasized that the recommendation is not “an exoneration of Arthur Sackler or an endorsement of his actions.” It also recommended that an effort be made to communicate Arthur Sackler’s legacy on the museum’s website and within the museum and building.